Diagnostic Code 7620 · 38 CFR §4.116
DC 7620 covers complete atrophy of both ovaries — meaning both ovaries have wasted away or shrunk to the point of being nonfunctional, without surgical removal. This can result from autoimmune conditions, radiation exposure, chemotherapy, severe infections, hormonal disorders, or toxic exposures that damaged the ovarian tissue. The effects are similar to surgical removal: premature menopause and all its associated health consequences including hot flashes, bone density loss, mood changes, and cardiovascular risk increases. Veterans may experience ovarian atrophy due to toxic exposures during service, radiation exposure, or as a side effect of treatment for other service-connected conditions.
| Rating | Criteria |
|---|---|
| 20% | Complete atrophy of both ovaries. The CFR provides a single rating of 20 percent for this condition. The ovaries are still physically present but have lost all or nearly all function. |
Hormone level testing showing menopausal levels of FSH and LH with low estrogen confirms ovarian failure. Serial lab results showing the progression of ovarian atrophy strengthen the case. Imaging studies (ultrasound or MRI) showing small, atrophic ovaries provide visual evidence. Medical records documenting the cause of ovarian atrophy (toxin exposure, radiation, chemotherapy, infection) connect it to service. Current records showing menopausal symptoms and their treatment demonstrate ongoing disability. An endocrinology or gynecology opinion linking the ovarian atrophy to service-related causes is often essential.
Blood tests are the key evidence. Elevated FSH (follicle-stimulating hormone) and low estradiol levels confirm ovarian failure. Imaging showing small, shrunken ovaries supports the diagnosis. Get these tests done through your doctor and include the results with your claim. Serial testing over time showing consistently menopausal levels is the strongest proof.
Yes. Certain chemicals, radiation, and medications can damage or destroy ovarian tissue. Agent Orange, burn pit exposure, radiation from military equipment, and chemotherapy drugs are all documented causes. If you were exposed to any of these during service, that exposure could be the basis for connecting your ovarian atrophy to service.
The CFR sets 20 percent for complete atrophy under DC 7620 and 30 percent for surgical removal of both ovaries under DC 7619. The difference may seem inconsistent, but these are the established rates. You can still file secondary claims for all the downstream effects (osteoporosis, depression, cardiovascular disease) and apply for special monthly compensation, which can significantly increase your total compensation.